| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
|
Green, M.R.
|
|
|
17 |
8 |
p. 1263-1268
|
artikel
|
| 2 |
Alternative clinical end points in rectal cancer—are we getting closer?
|
Glynne-Jones, R.
|
|
|
17 |
8 |
p. 1239-1248
|
artikel
|
| 3 |
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
|
Gietema, J.A.
|
|
|
17 |
8 |
p. 1320-1327
|
artikel
|
| 4 |
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours
|
Greystoke, A.
|
|
|
17 |
8 |
p. 1313-1319
|
artikel
|
| 5 |
A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients
|
Landgren, O.
|
|
|
17 |
8 |
p. 1290-1295
|
artikel
|
| 6 |
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
|
Van den Wyngaert, T.
|
|
|
17 |
8 |
p. 1197-1204
|
artikel
|
| 7 |
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study
|
Riedinger, J.M.
|
|
|
17 |
8 |
p. 1234-1238
|
artikel
|
| 8 |
Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study
|
Battaglioli, T.
|
|
|
17 |
8 |
p. 1283-1289
|
artikel
|
| 9 |
Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population
|
Bleiberg, H.
|
|
|
17 |
8 |
p. 1328-1332
|
artikel
|
| 10 |
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
|
Roché, H.
|
|
|
17 |
8 |
p. 1221-1227
|
artikel
|
| 11 |
Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95–01)
|
Vergnenegre, A.
|
|
|
17 |
8 |
p. 1269-1274
|
artikel
|
| 12 |
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
|
Ardine, M.
|
|
|
17 |
8 |
p. 1336-1337
|
artikel
|
| 13 |
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients
|
Zinzani, P.L.
|
|
|
17 |
8 |
p. 1296-1300
|
artikel
|
| 14 |
Effects of new smoking regulations
|
Levi, F.
|
|
|
17 |
8 |
p. 1335
|
artikel
|
| 15 |
Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review
|
Schöffski, P.
|
|
|
17 |
8 |
p. 1185-1196
|
artikel
|
| 16 |
Extranuclear expression of hormone receptors in primary breast cancer
|
Kim, R.
|
|
|
17 |
8 |
p. 1213-1220
|
artikel
|
| 17 |
First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer
|
Masi, G.
|
|
|
17 |
8 |
p. 1249-1254
|
artikel
|
| 18 |
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours
|
McTiernan, A.
|
|
|
17 |
8 |
p. 1301-1305
|
artikel
|
| 19 |
Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma
|
Simonelli, C.
|
|
|
17 |
8 |
p. 1335-1336
|
artikel
|
| 20 |
in this issue
|
|
|
|
17 |
8 |
p. 1179
|
artikel
|
| 21 |
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
|
Zell, J.A.
|
|
|
17 |
8 |
p. 1255-1262
|
artikel
|
| 22 |
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
|
Penack, O.
|
|
|
17 |
8 |
p. 1306-1312
|
artikel
|
| 23 |
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling
|
Tournilhac, O.
|
|
|
17 |
8 |
p. 1275-1282
|
artikel
|
| 24 |
Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era
|
Berretta, M.
|
|
|
17 |
8 |
p. 1333-1334
|
artikel
|
| 25 |
Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
|
Hupperets, P.S.
|
|
|
17 |
8 |
p. 1181-1183
|
artikel
|
| 26 |
Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
|
Tubiana-Hulin, M.
|
|
|
17 |
8 |
p. 1228-1233
|
artikel
|
| 27 |
Successful recovery after accidental overdose of cyclophosphamide
|
Aguiar Bujanda, D.
|
|
|
17 |
8 |
p. 1334
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
17 |
8 |
p. i-ii
|
artikel
|
| 29 |
The multidisciplinary management of patients with cancer
|
Mileshkin, L.
|
|
|
17 |
8 |
p. 1337-1338
|
artikel
|
| 30 |
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen
|
Martín, M.
|
|
|
17 |
8 |
p. 1205-1212
|
artikel
|
Tijdschrift beschrijving